ARS Pharmaceuticals, Inc.

Ownership Transactions Reported by 29 Insiders

Symbol
SPRY on Nasdaq
Industry
Pharmaceutical Preparations
Location
11682 El Camino Real, Suite 120, San Diego, California

Insiders trading volume in the past year

ARS Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sarina Tanimoto CHIEF MEDICAL OFFICER, 10%+ Owner $198M -$12.2M -5.82% Aug 20, 2024
Richard E. Lowenthal PRESIDENT AND CEO, Director, 10%+ Owner $198M -$12.2M -5.82% Aug 20, 2024
Ra Capital Management, L.P. Director, 10%+ Owner $97.5M +$21.5M +28.2% Jun 20, 2024
Pratik Shah Director $44.1M Jun 20, 2024
James E. Flynn Director, Director by deputization, 10%+ Owner $41.9M Nov 8, 2022
Laura Shawver Director $796K Jun 20, 2024
Alexander A. Fitzpatrick Chief Legal Officer $338K +$320K +1819% Jan 2, 2024
Jonathan Piazza Chief Financial Officer $262K May 2, 2022
Valerie Odegard President and CSO $233K May 2, 2022
Kathleen Scott Chief Financial Officer $211K -$200K -48.6% Aug 20, 2024
Naomi Hunder Chief Medical Officer $206K May 2, 2022
Jeffrey C. Pepe Interim CEO and GC $198K Sep 2, 2022
Russ Hawkinson Sr. Vice President of Finance $141K May 2, 2022
Brian Dorsey Chief Operating Officer $90.4K -$1.14M -92.7% Aug 20, 2024
Eric Karas Chief Commercial Officer $79.7K -$140K -63.7% Aug 19, 2024
Peter A. Thompson Director $0 -$12.6M -100% Aug 26, 2024
Orbimed Advisors Llc Director $0 -$12.6M -100% Aug 26, 2024
Phillip M. Schneider Director Jun 20, 2024
Saqib Islam Director Jun 20, 2024
Rajeev Dadoo Director Jun 20, 2024
Justin Chakma Chief Business Officer Jan 2, 2024
Michael Kelly Director Jun 20, 2024
Jonathan Leff Director Nov 8, 2022
L. Saunders Director Jun 20, 2024
Maria Koehler Director Jun 10, 2022
Jonathan Root Director Jun 10, 2022
Vickie L. Capps Director Jun 10, 2022
Andrew Kenneth William Powell Director Jun 10, 2022
Robert Hershberg Director Jun 10, 2022

Recent Insider Transactions by Companies or Individuals for ARS Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.